These experimental results confirmed that overexpression of DUXAP8 inhibited glycolysis and induced apoptosis of AML cells, ultimately inhibiting the activation of the Wnt/β-catenin signaling pathway. Here, DUXAP8 is linked to acute myeloid leukemia.